Regulation of CD95/APO-1/Fas-induced apoptosis by protein phosphatases

Biochemical Pharmacology

Volumn 76, Issue 11, 2008, Pages 1451-1458

  Gloire, Geoffrey ^a   Charlier, Edith ^a   Piette, Jacques ^a  

^a GIGA R   (Belgium)

Author keywords

Apoptosis; CD95; FAP 1; PTP; SHP 1; Tyrosine phosphorylation

Indexed keywords

CASPASE; FAS ANTIGEN; FAS LIGAND; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 1;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 56049121909     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.06.023     Document Type: Article

References (97)

1. Lavrik I., Golks A., and Krammer P.H. Death receptor signaling. J Cell Sci 118 Part 2 (2005) 265-267
2. Peter M.E., and Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10 1 (2003) 26-35
3. Siegel R.M., Frederiksen J.K., Zacharias D.A., Chan F.K., Johnson M., Lynch D., et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288 5475 (2000) 2354-2357
4. Papoff G., Hausler P., Eramo A., Pagano M.G., Di Leve G., Signore A., et al. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 274 53 (1999) 38241-38250
5. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85 6 (1996) 817-827
6. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14 22 (1995) 5579-5588
7. Lavrik I.N., Golks A., Baumann S., and Krammer P.H. Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood 108 2 (2006) 559-565
8. Medema J.P., Scaffidi C., Kischkel F.C., Shevchenko A., Mann M., Krammer P.H., et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16 10 (1997) 2794-2804
9. Chen M., Orozco A., Spencer D.M., and Wang J. Activation of initiator caspases through a stable dimeric intermediate. J Biol Chem 277 52 (2002) 50761-50767
10. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., et al. A unified model for apical caspase activation. Mol Cell 11 2 (2003) 529-541
11. Droin N., Bichat F., Rebe C., Wotawa A., Sordet O., Hammann A., et al. Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. Blood 97 6 (2001) 1835-1844
12. Kischkel F.C., Lawrence D.A., Tinel A., LeBlanc H., Virmani A., Schow P., et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276 49 (2001) 46639-46646
13. Wang J., Chun H.J., Wong W., Spencer D.M., and Lenardo M.J. Caspase-10 is an initiator caspase in death receptor signalling. Proc Natl Acad Sci USA 98 24 (2001) 13884-13888
14. Milhas D., Cuvillier O., Therville N., Clave P., Thomsen M., Levade T., et al. Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 280 20 (2005) 19836-19842
15. Sprick M.R., Rieser E., Stahl H., Grosse-Wilde A., Weigand M.A., and Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 21 17 (2002) 4520-4530
16. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17 6 (1998) 1675-1687
17. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 4 (1998) 481-490
18. Bao Q., and Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 14 1 (2007) 56-65
19. Krueger A., Schmitz I., Baumann S., Krammer P.H., and Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276 23 (2001) 20633-20640
20. Krammer P.H., Arnold R., and Lavrik I.N. Life and death in peripheral T cells. Nat Rev Immunol 7 7 (2007) 532-542
21. Brenner D., Krammer P.H., and Arnold R. Concepts of activated T cell death. Crit Rev Oncol Hematol 66 1 (2008) 52-64
22. Bidere N., Su H.C., and Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 24 (2006) 321-352
23. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 6367 (1992) 314-317
24. Nagata S. Mutations in the Fas antigen gene in lpr mice. Semin Immunol 6 1 (1994) 3-8
25. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76 6 (1994) 969-976
26. Reinehr R., and Haussinger D. CD95 activation in the liver: ion fluxes and oxidative signaling. Arch Biochem Biophys 462 2 (2007) 124-131
27. Wajant H., and CD95L/FasL. TRAIL in tumour surveillance and cancer therapy. Cancer Treat Res 130 (2006) 141-165
28. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.O., Newell M.K., et al. The CD95 receptor: apoptosis revisited. Cell 129 3 (2007) 447-450
29. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7 11 (2006) 833-846
30. Mustelin T., Vang T., and Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 5 1 (2005) 43-57
31. den Hertog J., Ostman A., and Bohmer F.D. Protein tyrosine phosphatases: regulatory mechanisms. FEBS J 275 5 (2008) 831-847
32. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., et al. Protein tyrosine phosphatases in the human genome. Cell 117 6 (2004) 699-711
33. Erdmann K.S. The protein tyrosine phosphatase PTP-Basophil/Basophil-like. Interacting proteins and molecular functions. Eur J Biochem 270 24 (2003) 4789-4798
34. Ciccarelli F.D., Bork P., and Kerkhoff E. The KIND module: a putative signalling domain evolved from the C lobe of the protein kinase fold. Trends Biochem Sci 28 7 (2003) 349-352
35. Chishti A.H., Kim A.C., Marfatia S.M., Lutchman M., Hanspal M., Jindal H., et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23 8 (1998) 281-282
36. Sheng M., and Sala C. PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 24 (2001) 1-29
37. Abaan O.D., and Toretsky J.A. PTPL1: a large phosphatase with a split personality. Cancer Metastasis Rev (2008)
38. Sato T., Irie S., Kitada S., and Reed J.C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268 5209 (1995) 411-415
39. Saras J., Engstrom U., Gonez L.J., and Heldin C.H. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas. J Biol Chem 272 34 (1997) 20979-20981
40. Yanagisawa J., Takahashi M., Kanki H., Yano-Yanagisawa H., Tazunoki T., Sawa E., et al. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 272 13 (1997) 8539-8545
41. Li Y., Kanki H., Hachiya T., Ohyama T., Irie S., Tang G., et al. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells. Int J Cancer 87 4 (2000) 473-479
42. Itoh N., and Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268 15 (1993) 10932-10937
43. Cuppen E., Nagata S., Wieringa B., and Hendriks W. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem 272 48 (1997) 30215-30220
44. Meinhold-Heerlein I., Stenner-Liewen F., Liewen H., Kitada S., Krajewska M., Krajewski S., et al. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am J Pathol 158 4 (2001) 1335-1344
45. Yao H., Song E., Chen J., and Hamar P. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. Br J Cancer 91 9 (2004) 1718-1725
46. Wieckowski E., Atarashi Y., Stanson J., Sato T.A., and Whiteside T.L. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis. J Cell Biochem 100 1 (2007) 16-28
47. Lee S.H., Shin M.S., Lee H.S., Bae J.H., Lee H.K., Kim H.S., et al. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 32 3 (2001) 250-256
48. Lee S.H., Shin M.S., Lee J.Y., Park W.S., Kim S.Y., Jang J.J., et al. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas. J Pathol 188 2 (1999) 207-212
49. Ungefroren H., Voss M., Jansen M., Roeder C., Henne-Bruns D., Kremer B., et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 58 8 (1998) 1741-1749
50. Ungefroren H., Kruse M.L., Trauzold A., Roeschmann S., Roeder C., Arlt A., et al. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci 114 Part 15 (2001) 2735-2746
51. Ivanov V.N., Lopez Bergami P., Maulit G., Sato T.A., Sassoon D., and Ronai Z. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface. Mol Cell Biol 23 10 (2003) 3623-3635
52. Zhou Y.W., Komada Y., Inaba H., Azuma E., and Sakurai M. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. Cell Immunol 186 2 (1998) 103-110
53. Zhang X., Brunner T., Carter L., Dutton R.W., Rogers P., Bradley L., et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185 10 (1997) 1837-1849
54. Arai M., Kannagi M., Matsuoka M., Sato T., Yamamoto N., and Fujii M. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. AIDS Res Hum Retroviruses 14 3 (1998) 261-267
55. Simon H.U., Yousefi S., Dibbert B., Hebestreit H., Weber M., Branch D.R., et al. Role for tyrosine phosphorylation and Lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils. Blood 92 2 (1998) 547-557
56. Eischen C.M., Dick C.J., and Leibson P.J. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153 5 (1994) 1947-1954
57. Atkinson E.A., Ostergaard H., Kane K., Pinkoski M.J., Caputo A., Olszowy M.W., et al. A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J Biol Chem 271 11 (1996) 5968-5971
58. Sharif-Askari E., Gaucher D., Halwani R., Ma J., Jao K., Abdallah A., et al. p56Lck tyrosine kinase enhances the assembly of death-inducing signaling complex during Fas-mediated apoptosis. J Biol Chem 282 49 (2007) 36048-36056
59. Reinehr R., Becker S., Eberle A., Grether-Beck S., and Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280 29 (2005) 27179-27194
60. Eberle A., Reinehr R., Becker S., and Haussinger D. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells. Hepatology 41 2 (2005) 315-326
61. Eberle A., Reinehr R., Becker S., Keitel V., and Haussinger D. CD95 tyrosine phosphorylation is required for CD95 oligomerization. Apoptosis 12 4 (2007) 719-729
62. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schutze S., et al. The role of receptor internalization in CD95 signaling. EMBO J 25 5 (2006) 1009-1023
63. Foehr E.D., Lorente G., Vincent V., Nikolich K., and Urfer R. FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS. J Neurooncol 74 3 (2005) 241-248
64. Komada Y., Inaba H., Zhou Y.W., Zhang X.L., Tanaka S., and Azuma E. Sakurai M, mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines. Br J Haematol 99 2 (1997) 325-330
65. Huang W., Zhu C., Wang H., Horvath E., and Eklund E.A. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells. J Biol Chem 283 12 (2008) 7921-7935
66. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87 2 (1996) 307-317
67. Poole A.W., and Jones M.L. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 17 11 (2005) 1323-1332
68. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73 7 (1993) 1445-1454
69. Tsui H.W., Siminovitch K.A., de Souza L., and Tsui F.W. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4 2 (1993) 124-129
70. Su X., Zhou T., Wang Z., Yang P., Jope R.S., and Mountz J.D. Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2 4 (1995) 353-362
71. Daigle I., Yousefi S., Colonna M., Green D.R., and Simon H.U. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 8 1 (2002) 61-67
72. Jia S.H., Parodo J., Kapus A., Rotstein O.D., and Marshall J.C. Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8. J Biol Chem 283 9 (2008) 5402-5413
73. Takayama H., Lee M.H., and Shirota-Someya Y. Lack of requirement for SHP-1 in both Fas-mediated and perforin-mediated cell death induced by CTL. J Immunol 157 9 (1996) 3943-3948
74. Kozlowski M., Mlinaric-Rascan I., Feng G.S., Shen R., Pawson T., and Siminovitch K.A. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med 178 6 (1993) 2157-2163
75. Koncz G., Kerekes K., Chakrabandhu K., and Hueber A.O. Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling. Cell Death Differ 15 3 (2008) 494-503
76. Tonks N.K. PTP1B: from the sidelines to the front lines!. FEBS Lett 546 1 (2003) 140-148
77. Kenner K.A., Anyanwu E., Olefsky J.M., and Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271 33 (1996) 19810-19816
78. Flint A.J., Tiganis T., Barford D., and Tonks N.K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94 5 (1997) 1680-1685
79. Liu F., and Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem J 327 Part 1 (1997) 139-145
80. Cohen J., Altaratz H., Zick Y., Klingmuller U., and Neumann D. Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases. Biochem J 327 Part 2 (1997) 391-397
81. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 5407 (1999) 1544-1548
82. Sangwan V., Paliouras G.N., Cheng A., Dube N., Tremblay M.L., and Park M. Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure. J Biol Chem 281 1 (2006) 221-228
83. Cohen P.T. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 22 7 (1997) 245-251
84. Barford D. Molecular mechanisms of the protein serine/threonine phosphatases. Trends Biochem Sci 21 11 (1996) 407-412
85. Chatfield K., and Eastman A. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways. Biochem Biophys Res Commun 323 4 (2004) 1313-1320
86. Harmala-Brasken A.S., Mikhailov A., Soderstrom T.S., Meinander A., Holmstrom T.H., Damuni Z., et al. Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. Oncogene 22 48 (2003) 7677-7686
87. Alvarado-Kristensson M., and Andersson T. Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem 280 7 (2005) 6238-6244
88. Alvarado-Kristensson M., Melander F., Leandersson K., Ronnstrand L., Wernstedt C., and Andersson T. p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J Exp Med 199 4 (2004) 449-458
89. Van Hoof C., and Goris J. Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. Biochim Biophys Acta 1640 2-3 (2003) 97-104
90. Klumpp S., Thissen M.C., and Krieglstein J. Protein phosphatases types 2Calpha and 2Cbeta in apoptosis. Biochem Soc Trans 34 Part 6 (2006) 1370-1375
91. Garcia A., Cayla X., Guergnon J., Dessauge F., Hospital V., Rebollo M.P., et al. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 85 8 (2003) 721-726
92. Toker A., and Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 6634 (1997) 673-676
93. Stokoe D. Pten. Curr Biol 11 13 (2001) R502
94. Suzuki A., Nakano T., Mak T.W., and Sasaki T. Portrait of PTEN: messages from mutant mice. Cancer Sci 99 2 (2008) 209-213
95. Di Cristofano A., Kotsi P., Peng Y.F., Cordon-Cardo C., Elkon K.B., and Pandolfi P.P. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285 5436 (1999) 2122-2125
96. Strauss G., Knape I., Melzner I., and Debatin K.M. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells. J Immunol 171 3 (2003) 1172-1182
97. Jones R.G., Elford A.R., Parsons M.J., Wu L., Krawczyk C.M., Yeh W.C., et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 196 3 (2002) 335-348